Your portfolio is characterized by a significant concentration in healthcare, with AbbVie Inc alone constituting 34% of the portfolio. This is complemented by a variety of asset types, including common stocks, ETFs, and funds, though it's heavily weighted towards stocks at 85%. The presence of both bullish and bearish ETFs indicates an attempt to hedge against market volatility. However, the heavy weighting in a single stock and sector suggests potential vulnerability to sector-specific risks.
Historically, your portfolio has achieved a Compound Annual Growth Rate (CAGR) of 14.34%, with a maximum drawdown of -12.13%. These figures suggest a robust performance, especially given the relatively moderate maximum drawdown, which indicates resilience during market downturns. The days contributing most to returns highlight the impact of significant market movements on portfolio performance. Comparing these metrics to benchmarks could provide further insight into relative performance.
Using Monte Carlo simulations, which project future performance based on historical data, your portfolio shows a wide range of potential outcomes. The 50th percentile outcome suggests a potential 230.8% increase, indicating strong growth prospects. However, the 5th percentile outcome at -79.4% underscores the risk of significant losses. These projections are a helpful reminder of the inherent uncertainties in investing, emphasizing the importance of diversification and risk management.
The asset allocation, predominantly in stocks with a minor allocation in cash and other assets, reflects a growth-oriented strategy. This composition is suitable for investors with a moderate risk tolerance but may need adjustments to align with your risk profile more closely. Diversifying further into bonds or other asset classes could provide a more balanced risk-return profile, especially in volatile market conditions.
Your portfolio's sector allocation reveals a heavy emphasis on healthcare and communication services, with less exposure to sectors like technology, industrials, and consumer cyclicals. This concentrated exposure to healthcare could lead to higher volatility linked to regulatory changes or market sentiment in this sector. Considering a more balanced sector distribution could mitigate sector-specific risks and capitalize on growth opportunities across the economy.
With 80% of assets allocated in North America and limited exposure to international markets, your portfolio could be missing out on diversification benefits and growth opportunities in emerging and developed markets outside the U.S. Expanding geographic exposure could reduce the impact of regional economic downturns and tap into growth in other parts of the world.
The focus on mega and big cap stocks suggests a preference for stability and established companies, which is consistent with a balanced risk profile. However, incorporating medium or even small cap stocks could enhance growth potential, albeit with increased volatility. This adjustment could offer a balanced approach to capital appreciation and risk.
The high correlation between certain assets, notably Alphabet Inc Class A and Direxion Daily GOOGL Bull 1.5X Shares, indicates overlapping exposures that may not contribute to diversification. Reducing holdings in highly correlated assets could lower portfolio volatility and improve overall risk management.
This chart shows the Efficient Frontier, calculated using your current assets with different allocation combinations. It highlights the best balance between risk and return based on historical data. "Efficient" portfolios maximize returns for a given risk or minimize risk for a given return. Portfolios below the curve are less efficient. This is informational and not a recommendation to buy or sell any assets.
Click on the colored dots to explore allocations.
Optimizing your portfolio along the Efficient Frontier could achieve a better risk-return ratio. The current alignment suggests room for improvement in diversification and risk management without sacrificing expected returns. Consider rebalancing to reduce overlap in correlated assets and increase exposure to underrepresented sectors and geographies.
The overall dividend yield of 3.38% is a notable component of your portfolio's total return, providing a steady income stream. This focus on dividends is beneficial in a balanced portfolio, offering a cushion during market downturns. However, ensuring that high dividend yields do not come at the expense of growth potential or excessive concentration in specific sectors or stocks is crucial.
The Total Expense Ratios (TER) of the ETFs and funds in your portfolio vary significantly, from 0.06% to over 1%. These costs, while seemingly small, can compound over time, impacting long-term returns. Focusing on reducing these costs by selecting lower-cost alternatives or rebalancing towards direct stock holdings could enhance net returns.
Select a broker that fits your needs and watch for low fees to maximize your returns.
How much do the funds you hold actually overlap with the ones people weigh them against?
The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.
Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.
Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.
Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.
By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.
Instrument logos provided by Elbstream.
Your feedback makes a difference! Share your thoughts in our quick survey. Take the survey